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Cardiac hypertrophy is often characterized by abnormali- 
ties in myocardial perfusion, including decreased coronary 
reserve, increased minimal coronary vascular resistance, 
underperfusion of the subendomyocardium during condi- 
tions of high oxygen demand and increased risk of infarc- 
tion in the presence of coronary occlusion. Two major 
anatomic variables may cause these perfusion deficits. 
First, the coronary resistance vessels may not grow in 
proportion to the magnitude of the cardiac enlargement. 
Second, the luminal diameter of resistance vessels may 
become reduced as a consequence of medial hypertrophy, 
hyperplasia or fibrosis. A luminal narrowing coupled with 
a lack or inadequate numeric proliferation of resistance 
vessels can markedly limit maximal myocardial perfusion. 
Although it has long been recognized that patients with left 
ventricular hypertrophy usually have normal coronary flow 
per unit mass under conditions at rest (1,2), perfusion 
abnormalities under conditions requiring enhanced oxygen 
utilization are commonly observed (3-5). Numerous studies 
(3-26) on patients and experimental animals suggest that 
coronary reserve is at least mildly impaired in cardiac 
hypertrophy secondary to pressure or volume overload. 
Because this diminution of reserve occurs even in the 
absence of occlusive coronary artery disease, it is evident 
that limitations in myocardial perfusion involve small coro- 
nary arteries. There is now considerable evidence indicating 
that cardiac hypertrophy is associated with decreased max- 
imal coronary perfusion resulting from decreased cross- 
sectional area of the major resistance vessels, that is, the 
arterioles. 
In addressing the effects of hypertrophy of various origins 
on the coronary circulation, three major points should be 
considered. First, insufficient angiogenesis may in itself 
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However, not all models of cardiac hypertrophy are 
characterized by perfusion abnormalities. A substantial 
growth of arterioles and capillaries has been documented in 
exercise- and thyroxine-induced left ventricular hypertro- 
phy. Moreover, at least in some models, angiogenesis 
occurs when the duration of the ventricular hypertrophy is 
sufficient. The hypothesis that coronary angiogenesis is 
stimulated by increased blood flow or prolongation of 
diastole appears to have support from a number of exper- 
imental studies. However, the cascade of events underlying 
angiogenesis and the numerous variables that characterize 
the various models of hypertrophy are complex and require 
elucidation. 
(J Am Co11 Cardiol1990;15:528-33) 
account for the observed decrease in coronary perfusion 
commonly observed in hypertrophied hearts. Second, small 
coronary arteries may, at least in some forms of hyperten- 
sion, undergo vascular remodeling, thereby contributing to 
perfusion abnormalities. Third, a substantial angiogenesis 
may occur in cardiac hypertrophy; this vascular growth is 
dependent on a number of factors, including age and the 
stimulus that evokes the cardiac hypertrophy. 
Adverse Effects of Cardiac Hypertrophy on 
the Coronary Circulation 
Decrease in maximal myocardial perfusion. This is most 
commonly observed when left ventricular hypertrophy is 
secondary to pressure overload. Left ventricular coronary 
reserve, as measured with the argon clearance method 
before and after maximal coronary vasodilation, has been 
shown to be compromised in patients with aortic stenosis 
(10,15). Using a Doppler probe, Marcus et al. (11,13) have 
also examined the reactive hyperemic responses in adults 
and children with aortic stenosis at the time of cardiac 
surgery before cardiopulmonary bypass. In these patients, 
they noted normal hyperemic responses of right ventricular 
coronary arteries but severely blunted responses of the left 
ventricular descending artery. Most of the patients studied 
demonstrated a hyperemic response that was only about 
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25% to 40% of that observed in the coronary arteries of the 
right ventricle. Although the magnitude of left ventricular 
hypertrophy in such patients is often severe, Strauer et al. 
(10) found that coronary reserve could be reduced even in 
instances where the magnitude of left ventricular hypertro- 
phy was mild to moderate. In patients with left ventricular 
hypertrophy associated with volume overload, coronary 
reserve has also been found to be compromised as deter- 
mined by the Doppler reactive hyperemia and the argon 
methods (10,15,16). The hypertrophied right ventricle in 
both pressure and volume overload is also characterized by 
a diminished coronary reserve (5). 
Experimental studies. A variety of experimental studies 
involving several species have demonstrated that ventricular 
hypertrophy evoked by pressure overload is associated with 
limitations in maximal coronary flow (6-9,12,14,17- 
21,23,24,26). These studies have utilized radioactive micro- 
spheres to measure both total and regional ventricular per- 
fusion. Both left and right ventricular hypertrophy 
associated with pressure overload have been shown to result 
in a decreased coronary vasodilator reserve (6,14,19,22.24) 
and an elevated minimal coronary vascular resistance 
(8,12,14,17,18,23.25,26) during pharmacologically induced 
maximal vasodilation. In some cases the major coronary 
abnormality may be an underperfusion of the endocardial 
layer (6). Chronic left ventricular hypertrophy may predis- 
pose the deeper layers of the myocardium to underperfusion 
during exercise stress, an abnormality that has been demon- 
strated in canine (9,18) and porcine (21) models. Recent 
evidence (26) also documents an abnormality of local control 
of myocardial perfusion in dogs with renovascular hyperten- 
sion (one kidney. one clip) and left ventricular hypertrophy. 
When circumflex artery pressure was reduced in control 
dogs, neither total myocardial perfusion nor transmural 
distribution of flow was altered. However, in dogs with 
hypertension and left ventricular hypertrophy, lowering of 
pressure from 100 to 40 mm Hg decreased subendocardial 
perfusion by 46%. Thus, this study shows that hypertension 
and left ventricular hypertrophy are associated with clear- 
cut impairment of subendomyocardial autoregulation. 
Experimental evidence ulso supports clinical obsen!a- 
tions that when coronary occlusion is present hypertension 
und left ventriculur hypertrophy predispose the myocardium 
to a risk of infarction and death. Dogs with hypertension and 
left ventricular hypertrophy had five times the mortality rate 
within the first 48 h after coronary occlusion when compared 
with control dogs (27). This observation is consistent with 
the finding that the infarct size/left ventricular mass ratio is 
higher in the dogs with left ventricular hypertrophy and 
hypertension over a range of risk area/left ventricular mass 
ratio of approximately 10% to 50% (28). These data provide 
evidence that hypertension-induced left ventricular hyper- 
trophy increases the infarct size and the incidence of mor- 
tality when the myocardium is subjected to ischemia. 
Hoti*e\,er, crt least some abnormalities in the coronary 
circulation may be dependent on the model used. Hyperten- 
sion itself may contribute to the commonly observed in- 
crease in minimal coronary vascular resistance per unit 
mass. When the development of hypertension in spontane- 
ously hypertensive rats was prevented with long-term hy- 
dralazine treatment, left ventricular minimal coronary vas- 
cular resistance per unit mass was normal despite the 
presence of left ventricular hypertrophy (17). A similar effect 
was seen when the vasodilator was administered to the 
normotensive Wistar Kyoto rats. Further support for the 
hypothesis that hypertension contributes to an elevated 
minimal coronary vascular resistance per unit mass in this 
model comes from data on the right ventricle, which does 
not experience hypertrophy. In the presence of hyperten- 
sion, right ventricular minimal coronary vascular resistance 
per unit mass was elevated (14,17), but when hypertension 
was precluded with hydralazine treatment, the normal val- 
ues were similar to values in the Wistar Kyoto control rats 
(17). 
Structural Bases for Maximal 
Myocardial Perfusion 
The precapillary resistance vessels. Blood perfusion of the 
myocardium is primarily regulated by the major resistance 
vessels. As previously demonstrated, precapillary vessels 
~300 pm in diameter account for most of the resistance in 
the coronary bed (29). Maximal flow is then determined by 
the driving pressure and the cross-sectional areas of these 
vessels. When ventricular hypertrophy develops, minimal 
coronary vascular resistance may be altered or unchanged 
depending on the response of the resistance vessels. Figure 
1 shows a schematic diagram that includes the possible 
reactions of the coronary resistance vessels and the effect of 
the reactions on minimal coronary vascular resistance 
expressed two different ways: 1) total minimal coronary 
vascular resistance (resistance per entire ventricle), and 
2) minimal coronary vascular resistance per 100 g. As shown 
in Figure 1. if vascular growth is proportional to the magni- 
tude of hypertrophy, resistance per 100 g will be normal, 
whereas total minimal coronary vascular resistance will be 
decreased. In contrast, if vascular growth lags behind myo- 
cardial growth. minimal coronary vascular resistance per 100 
g will increase. A further impairment of maximal flow (and 
consequently an additional increase in minimal coronary 
vascular resistance per 100 g) occurs when medial hypertro- 
phy of the vessels results in luminal narrowing. A less likely 
possibility is an absolute reduction in the number of resis- 
tance vessels, a phenomenon (rarefaction) seen in other 
vascular beds during hypertensive states. 
Vascular medial hypertrophy in hypertension. Vascular 
hypertrophy with a reduction in wall/lumen ratio has been 
reported in coronary arterioles in spontaneously hyperten- 
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Figure 1. A schematic diagram illustrating the putative 
changes in resistance vessels occurring during cardiac 
hypertrophy (CH). The top right box shows prolifera- 
tion of vessels proportional to the magnitude of cardiac 
hypertrophy, resulting in a decrease in total minimal 
coronary vascular resistance (T MCVR) and an un- 
changed minimal coronary vascular resistance (MCVR) 
per 100 g. The three boxes in the bottom row show (from 
right to left) no vascular growth, decreased luminal 
diameter due to an increase in wall/lumen ratio, and 
vascular rarefaction due to dropout of terminal arteri- 
oles. This illustration is a modification of a schematic 
diagram originally presented by Mueller et al. (8). 
sive rats (17,30) and DOCA hypertensive rats (31). How- 
ever, such changes may be model or species dependent. My 
colleagues and I investigated the hierarchy of canine precap- 
illary vessels after 6 weeks (12) and 7 months (32) of 
renovascular hypertension and left ventricular hypertrophy. 
Wall/lumen ratios of all sizes of precapillary vessels were 
almost identical to those in the normotensive control dogs. 
Although medial thickening of coronary arteries and arteri- 
oles may occur in hypertensive states, a reduction in luminal 
diameter is not necessarily a consequence of such vascular 
remodeling. For example, coronary arteries may undergo 
medial thickening along with a concomitant increase in 
luminal diameter (12) or a medial thickening with no change 
in luminal diameter (33). Alterations in coronary vessels may 
be model dependent; for example, it has been suggested that 
elevated levels of angiotensin II may be responsible for 
extensive pathologic alterations in coronary arteries of rats 
(34). Thus, factors other than increased coronary pressure 
and cardiac hypertrophy may contribute to arterial and 
arteriolar structural alterations. Because nearly all experi- 
mental data on small vessels are based on young animals, the 
role of aging in structural alterations, including remodeling, 
is not well understood. 
Evidence for Vascular Growth 
Angiogenesis in left ventricular hypertrophy. Despite the 
evidence that most cases of cardiac hypertrophy are associ- 
ated with decreased coronary reserve and increased minimal 
coronary vascular resistance per unit mass, several studies 
have shown that these variables can be normal or even 
improved in some models and under certain conditions. 
When cardiac hypertrophy became stabilized in the sponta- 
neously hypertensive rat (aged 7 to 15 months) minimal 
coronary vascular resistance per unit mass decreased tc\ the 
level in the normotensive control rats (14). To test the 
hypothesis that long-term left ventricular hypertrophy due to 
hypertension may be characterized by angiogenesis compat- 
ible with the left ventricular hypertrophy, we recently stud- 
ied dogs after 7 months of one kidney, one clip hypertension 
(32). Although left ventricular mass increased by 47%, left 
ventricular minimal coronary vascular resistance per unit 
mass was similar to that of the control dogs, whereas total 
left ventricular minimal coronary vascular resistance was 
significantly lower. Arteriolar density, evaluated by morpho- 
metric methods, was found to be similar in the two groups 
for all size classes (Fig. 2). Evidence for some significant 
arteriolar growth is also found in a study (35) on pigs with 
aortic banding of 30 days’ duration. However, these findings 
may not apply to all models of pressure overload. For 
example, 6 months of hypertension and left ventricular 
hypertrophy induced by the two kidney, one clip model in 
dogs did not facilitate a normalization of left ventricular 
minimal coronary vascular resistance per unit mass (7). 
Thus, at least in these models and species, the duration of 
the left ventricular hypertrophy appears to be an important 
determinant of angiogenesis. 
Although the factors that might contribute to precapillary 
vascular growth need to be elucidated, it is evident that the 
stimulus for hypertrophy is of importance. Left ventricular 
enlargement due to 3 months of thyrotoxicosis in rats is 
characterized by a reduction in total minimal coronary 
vascular resistance and a concomitant increase in coronary 
reserve, compared with values in control rats (36). These 
findings indicate that growth of resistance vessels in this 
model may even exceed the growth of the myocardium. In 
support of this study are recent morphometric data from 
another laboratory (37) that show that arteriolar density is 
normal when triiodothyronine is administered to induce left 
ventricular hypertrophy. When exercise training is used to 
induce left ventricular hypertrophy in pigs, the response of 
the coronary vasculature may also be favorable, as shown by 
1) a normal minimal coronary vascular resistance per 100 g, 
and 2) a slightly increased arteriolar density (38). 
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Figure 2. Arteriolar profile density (no./mm’), where 
arterioles are defined as precapillary vessels ~200 pm in 
diameter. Three regions of the canine left ventricular 
free wall are represented: epimyocardium (EPI), mid- 
myocardium (MID) and endomyocardium (ENDO). The _ 
??Control (n=4) 0.4 
??LVH (n=8) 
0 
dogs with left ventricular hypertrophy were studled 7 
months after surgery (one kidney, one clip) to induce 
hypertension. Bars represent 1 SD. LVH = left ventric- 
ular hypertrophy. Data from Tomanek et al. (32). pub- 
lished with permission from the American Heart Asso- 
ciation. 
<30 
Capillary angiogenesis. This is of importance to the dis- 
cussion of precapillary vascular growth for at least two 
reasons. First, although capillaries contribute little to resis- 
tance, they are responsible for the distribution of flow at the 
cellular level. Second, new arterioles have been seen to 
develop from capillaries (39). Coronary capillary angiogen- 
esis during left ventricular hypertrophy has been demon- 
strated in two forms of hypertension in rodents. The capil- 
lary bed has been shown to grow in proportion to the muscle 
mass when the duration of the hypertrophy is long, for 
example, by the 15th month in the spontaneously hyperten- 
sive rat (40) and after 7 months in the one kidney, one clip 
model of left ventricular hypertrophy in the rat (Anversa P. 
personal communication). Even if capillary growth is not 
proportional to the magnitude of cardiac hypertrophy, some 
degree of growth may occur during pressure over1oa.i left 
ventricular hypertrophy. Evidence for this view comes from 
studies (41-43) that report only minor decreases in capillary 
numeric density despite more substantial increases in ven- 
tricular mass. 
Conditions Favoring Coronary Angiogenesis 
Mechanical factors. A summary of conditions that appear 
to facilitate capillary angiogenesis is provided in Table 1. 
Although growth factors are undoubtedly involved in angio- 
genie responses (53), the trigger for a cascade of events may 
be mechanical factors associated with increased blood flow 
(54). Indeed, support for this hypothesis comes from studies 
that documented capillary growth in the heart of animals that 
were treated with vasodilator drugs (44,46,47) or thyroxine 
(36), exposed to hypoxia (52) or exercise trained (44,45). 
Exercise-associated capillary angiogenesis occurred when it 
was the primary stimulus for left ventricular hypertrophy 
(44) and when it was imposed on young spontaneously 
hypertensive rats that developed left ventricular hypertro- 
30-49 50-w 100-200 <30 30.49 50-99 1 W-200 
LUMEN DIAMETERS (pm) 
phy in association with hypertension (45). Whereas these 
interventions clearly increase coronary blood flow, less is 
known about long-term left ventricular hypertrophy, which 
may also include coronary angiogenesis. However, one 
would expect that microvascular flow would increase as 
myocardial hypertrophy developed and intercapillary dis- 
tance increased. 
Bradycardia. Surprisingly, it appears that the most effec- 
tive experimental condition facilitating coronary capillary 
angiogenesis is bradycardial pacing, which has been shown 
to evoke exceptional increases in capillary numeric density 
in both hypertrophied and nonhypertrophied hearts (48,49). 
Although total myocardial flow decreases during bradycar- 
dia, flow per diastolic interval is increased. Further support 
for the angiogenic effect of prolonged diastole comes from 
studies (50.51) that have reported increased capillary nu- 
meric densities after long-term treatment with beta-blockade 
or sympathectomy. 
Hypothesis concerning capillary angiogenesis. Figure 3 
illustrates a hypothesis concerning capillary, and perhaps 
arteriolar. angiogenesis in response to either enhanced flow 
Table 1. Experimental Conditions Reported to Induce 
Angiogenesis of Myocardial Capillary and Precapillary Vessels 
Precapillary 
Capillaries Vessels 
(reference no.) (reference no.) 
Lung-term LVH 40 14, 32 
Exercise 44. 45* 38 
Coronary vasodilators 44. 46, 47 
Thyroxine 36 36, 31 
Bradycardia 48. 49 
Beta-blockade and sympathectomy 50. 51 
Hypoxia 52 
*Exercise-induced hypertrophy (44): exercised young spontaneously 
hypertensive rats (47). LVH = left ventricular hypertrophy. 
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Figure 3. Bradycardia or chronically elevated blood flow stimulated 
coronary angiogenesis. This illustration summarizes a hypothesis 
that angiogenesis, ultimately mediated by growth factors, may 
include stretch as an initiating stimulus. See text for further expla- 
nation. 
or bradycardia, a hypothesis largely based on the work and 
discussions of Hudlicka et al. (46,48,49,54). Central to the 
hypothesis is the increase in capillary diameter during dias- 
tole (Fig. 3); the dimensions shown here reflect measured 
changes in epicardial capillaries (55). Intramural capillaries 
would be expected to undergo a greater narrowing during 
systole. Increased flow during diastole, as might occur in 
states of enhanced oxygen demand, would constitute a 
mechanical stimulus (stretch) that could initiate a signal (or 
signals) for an angiogenic response resulting from growth 
factors. Bradycardia may affect a similar response because 
1) flow per diastole is increased, and 2) perhaps because the 
diastolic interval is longer (i.e., the vessel spends more time 
in a dilated position). 
Whereas many details of angiogenesis require documen- 
tation, the role of mechanical factors inherent in blood flow 
has considerable support (54). The idea that stretch, which 
flattens endothelial cells, stimulates proliferation is sup- 
ported by work demonstrating an increased deoxyribonu- 
cleic acid incorporation (56) and by the observation that 
fibroblastic growth factor is mitogenic only when the endo- 
thelial cell is under some degree of elongation (Folkman J, 
personal communication). These lines of evidence enhance 
the attractiveness of the concept that stretch may be an 
initiating signal in angiogenesis. 
Implications. Despite the recent intense interest in angio- 
genesis, the many factors that may influence this process 
during cardiac hypertrophy and their interactions are not 
well understood. As the complexities of the events that 
constitute the angiogenic response become unraveled, inter- 
ventions favoring coronary vascular growth may be identi- 
fied and used clinically. 
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